These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30046040)

  • 21. Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer.
    Ren T; Suo J; Liu S; Wang S; Shu S; Xiang Y; Lang JH
    J Gynecol Oncol; 2018 Sep; 29(5):e78. PubMed ID: 30022638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding genetic variability: exploring large-scale copy number variants through non-invasive prenatal testing in European populations.
    Holesova Z; Pös O; Gazdarica J; Kucharik M; Budis J; Hyblova M; Minarik G; Szemes T
    BMC Genomics; 2024 Apr; 25(1):366. PubMed ID: 38622538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.
    Khalil AIS; Khyriem C; Chattopadhyay A; Sanyal A
    BMC Bioinformatics; 2020 Apr; 21(1):147. PubMed ID: 32299346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses.
    Vanderstichele A; Busschaert P; Smeets D; Landolfo C; Van Nieuwenhuysen E; Leunen K; Neven P; Amant F; Mahner S; Braicu EI; Zeilinger R; Coosemans A; Timmerman D; Lambrechts D; Vergote I
    Clin Cancer Res; 2017 May; 23(9):2223-2231. PubMed ID: 27852697
    [No Abstract]   [Full Text] [Related]  

  • 25. Combinatory Analysis of Cell-free and Circulating Tumor Cell DNAs Provides More Variants for Cancer Treatment.
    Lee SY; Chae DK; An J; Yoo S; Jung S; Chae CH; Bhak J; Kim BC; Cho DH
    Anticancer Res; 2019 Dec; 39(12):6595-6602. PubMed ID: 31810925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients.
    Martignano F; Munagala U; Crucitta S; Mingrino A; Semeraro R; Del Re M; Petrini I; Magi A; Conticello SG
    Mol Cancer; 2021 Feb; 20(1):32. PubMed ID: 33579306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Structural Variation from NGS-Based Non-Invasive Prenatal Testing.
    Pös O; Budis J; Kubiritova Z; Kucharik M; Duris F; Radvanszky J; Szemes T
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing.
    Sun X; Liu X; Zhao Y; Tian G; Wang W
    Methods Mol Biol; 2023; 2695():27-46. PubMed ID: 37450110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circulating tumor DNA assessment for gynaecological cancers management].
    Mari R; Lambaudie É; Provansal M; Sabatier R
    Bull Cancer; 2019 Mar; 106(3):237-252. PubMed ID: 30765097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.
    Kang M; Cho E; Jang J; Lee J; Jeon Y; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Investig Clin Urol; 2019 Jul; 60(4):227-234. PubMed ID: 31294131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
    Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
    Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.
    Xia L; Li Z; Zhou B; Tian G; Zeng L; Dai H; Li X; Liu C; Lu S; Xu F; Tu X; Deng F; Xie Y; Huang W; He J
    Sci Rep; 2017 Aug; 7(1):7526. PubMed ID: 28790338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-free DNA copy number variations in plasma from colorectal cancer patients.
    Li J; Dittmar RL; Xia S; Zhang H; Du M; Huang CC; Druliner BR; Boardman L; Wang L
    Mol Oncol; 2017 Aug; 11(8):1099-1111. PubMed ID: 28504856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using massively parallel shotgun sequencing of maternal plasmatic cell-free DNA for cytomegalovirus DNA detection during pregnancy: a proof of concept study.
    Chesnais V; Ott A; Chaplais E; Gabillard S; Pallares D; Vauloup-Fellous C; Benachi A; Costa JM; Ginoux E
    Sci Rep; 2018 Mar; 8(1):4321. PubMed ID: 29531245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma.
    Nguyen MTN; Rajavuori A; Huhtinen K; Hietanen S; Hynninen J; Oikkonen J; Hautaniemi S
    Biomed Pharmacother; 2023 Dec; 168():115630. PubMed ID: 37806091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring.
    Zviran A; Schulman RC; Shah M; Hill STK; Deochand S; Khamnei CC; Maloney D; Patel K; Liao W; Widman AJ; Wong P; Callahan MK; Ha G; Reed S; Rotem D; Frederick D; Sharova T; Miao B; Kim T; Gydush G; Rhoades J; Huang KY; Omans ND; Bolan PO; Lipsky AH; Ang C; Malbari M; Spinelli CF; Kazancioglu S; Runnels AM; Fennessey S; Stolte C; Gaiti F; Inghirami GG; Adalsteinsson V; Houck-Loomis B; Ishii J; Wolchok JD; Boland G; Robine N; Altorki NK; Landau DA
    Nat Med; 2020 Jul; 26(7):1114-1124. PubMed ID: 32483360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer.
    Keserű JS; Soltész B; Lukács J; Márton É; Szilágyi-Bónizs M; Penyige A; Póka R; Nagy B
    J Biotechnol; 2019 Jun; 298():76-81. PubMed ID: 31002856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.